Myeloablative therapy followed by stem cell rescue for pediatric solid timors: A non-transplanter's perspective

Cancer Research, Therapy and Control

Volumn 9, Issue 1-2, 1999, Pages 95-99

  Woods, William G ^a,b  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

^b South Carolina Cancer Center   (United States)

Author keywords

Autologous bmt; Bone marrow transplantation (bmt); Ewing's sarcoma; Glioblastoma multiforme; Neuroblastoma; Pediatric malignancies; Pediatric solid tumors; Rhabdomyosarcoma; Wilms' tumor

Indexed keywords

ETOPOSIDE; MELPHALAN; MYELOABLATIVE AGENT;

AUTOLOGOUS BONE MARROW TRANSPLANTATION; CANCER RECURRENCE; CHILDHOOD CANCER; CONFERENCE PAPER; EWING SARCOMA; GLIOBLASTOMA; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; NEPHROBLASTOMA; NEUROBLASTOMA; PRIORITY JOURNAL; RHABDOMYOSARCOMA; SOLID TUMOR;

EID: 0032859809     PISSN: 10640525     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Pritchard J, McElwain TJ, Graham-Poll J, et. al, "High Dose Melphalan with Autologous Bone Marrow Rescue for Treatment of advanced Neuroblastoma", British Journal of Cancer 1982:48:86-92.
2. Matthay KK, Seeger RC, Reynolds CP, et. al., "Allogeneic vs. Autologous purged Bone Marrow Transplantation for Neuroblastoma: a report from the Children's Cancer Group", Journal of Clinical Oncology 1994;12:2382-2389.
3. Cangir A, Vietti TJ, Gehanea, et. al., "Ewing's Sarcoma Metastatic at Diagnosis: Results and Comparisons of Two Intergroup Ewing's Sarcoma Studies", Cancer 1990;66:887-893.
4. Ladenstein R, Lasset C, Pinkerton R, et. al. "Impact of megatherapy in children with high-risk Ewing's tumours in complete remission: a report from the EBMT Solid Tumour Registry", Bone Marrow Transplantation 1995;15:697-705.
5. Ladenstein R, Hartmann O, Pinkerton CR, et. al., "The role of megatherapy with Autologous Bone Marrow Rescue in Solid Tumours of Childhood", Annals of Oncology 1993;4: S45-S58.
6. Burdach S, Jürgens H, Peters C, et. al., "Myeloablative Radiochemotherapy and Hematopoietic Stem-Cell Rescue in Poor-Prognosis Ewing's Sarcoma", Journal of Clinical Oncology 1993;! 1:1482-1488.
7. Raney R, Tefft M, Maurer H, et. al., "Disease Patterns and Survival Rate in Children With Metastatic Soft-Tissue Sarcoma", Cancer 1988;62:1257-1266.
8. Raney B, Crist W, Maurer H, et. al., "Prognosis of Children with Soft Tissue Sarcoma Who Relapse after Achieving a Complete Response", Cancer 1983;52:44-50. [9] Crist W, Gehan E, Abdelsalam HR, et. al., "The Third Intergroup Rhabdomyosarcoma Study", Journal of Clinical Oncology 1995;13:610-613.
9. Horowitz ME, Kinsella TA, Wexler LH, et. al., "Total Body Irradiation and Autologous Bone Marrow Transplant in the Treatment of High-Risk Ewing's Sarcoma and Rhabdomyosarcoma", Journal of Clinical Oncology 1993;! 1:1911-1918.
10. Grundy P, Breslow N, Green D, et al., "Prognostic Factors for Children With Recurrent Wilms' Tumor: Results From the Second and Third National Wilms' Tumor Study" Journal of Clinical Oncology 1989;7:638-647.
11. Garaventa A, Hartmann O, Bernard J, et. al., "Autologous Bone Marrow Transplantation for Pediatric Wilms' Tumor: The Experience of the European Bone Marrow Transplantation Solid Tumor Registry", Medical and Pediatric Oncology 1994;22:11-14.
12. Finlay J, Personal Communication.
13. Heideman R, Douglass E, Krancej R, et al., "High-Dose Chemotherapy and Autologous Bone Marrow Rescue Followed by Interstitial and External-Beam Radiotherapy in Newly Diagnosed Pediatrie Malignant Gliomas", Journal of Clinical Oncology 1993;11:1458-1465.
14. Stram D, Matthay K, O'Leary M, et. al., "Consolidation Chemoradiotherapy and Autologous Bone Marrow Transplantation Versus Continued Chemotherapy for Metastatic Neuroblastoma: A Report of Two Concurrent Children's Cancer Group Studies", Journal of Clinical Oncology 1996;14:2417-2426.
15. Philip T, Sucker TM, Bernard DIM, et. al., "Improved Survival at 2 and 5 Years in the LMCE1 Unselected Group of 72 Children With Stage IV Neuroblastoma Older Than 1 Year of Age at Diagnosis: Is Cure Possible in a Small Subgroup?", Journal of Clinical Oncology 1991;9:1037-1044.